Absence of new thymidine-associated mutations and evidence of an immune virologic response over a 12-month period in a cohort of antiretroviral-experienced HIV-1-infected subjects treated with tenofovir combination therapy

J Acquir Immune Defic Syndr. 2005 Oct 1;40(2):238-41. doi: 10.1097/01.qai.0000178409.62675.f9.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adenine / administration & dosage
  • Adenine / analogs & derivatives*
  • Adenine / therapeutic use
  • Cohort Studies
  • Drug Resistance, Viral / genetics
  • Drug Therapy, Combination
  • HIV Infections / drug therapy*
  • HIV Infections / immunology
  • HIV Infections / virology
  • HIV-1 / genetics
  • Humans
  • Mutation*
  • Organophosphonates / administration & dosage
  • Organophosphonates / therapeutic use*
  • Reverse Transcriptase Inhibitors / administration & dosage
  • Reverse Transcriptase Inhibitors / therapeutic use*
  • Tenofovir
  • Thymidine / genetics*
  • Viral Load

Substances

  • Organophosphonates
  • Reverse Transcriptase Inhibitors
  • Tenofovir
  • Adenine
  • Thymidine